SEC Form 4 · accession 0000884731-16-000038
ARIAD PHARMACEUTICALS INC · ARIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martin J Duvall
Officer — EVP, CCO
Period of report
Apr 29, 2016
Accepted (ET)
May 2, 2016 · 5:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 29, 2016 | M | 18,000 | $0.00 | A | 111,039 | D | |
| Common StockF1 | Apr 29, 2016 | F | 5,850 | $7.18 | D | 105,189 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F3 | $0.00 | Apr 29, 2016 | M | 18,000 | D | — | — | Common Stock | 18,000 | 0 | D |
Explanation of responses
- F1Represents shares withheld to satisfy withholding tax requirements
- F2Restricted stock units vest as to 33-1/3% of the award on each of April 29, 2016, April 29, 2017 and April 29, 2018.
- F3N/A